TS8A Stock Chart & Stats
€3.80
€0.04(0.91%)
At close: 4:00 PM EDT
€3.80
€0.04(0.91%)
Day’s Range― - ―
52-Week Range€3.36 - €6.90
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€49.18M
Enterprise Value€217.00
Total Cash (Recent Filing)€235.00K
Total Debt (Recent Filing)€141.14M
Price to Earnings (P/E)―
Beta0.63
Next Earnings
Dec 07, 2026EPS Estimate
-0.24Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.51
Shares Outstanding14,493,035
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio-0.73
Price to Book (P/B)0.72
Price to Sales (P/S)0.24
P/FCF Ratio3.54
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€6.01Price Target Upside58.25% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)-1.47
Revenue Forecast (FY)€180.84M
Bulls Say, Bears Say
Bulls Say
Positive Cash GenerationSustained positive operating and free cash flow gives DLH an internal funding source for operations, debt service, and selective investment. Although recent cash generation weakened, the multi-year record of positive free cash flow supports resilience while profitability is under pressure.
Internal Leadership ContinuityAn internally driven CEO and CFO transition can preserve customer relationships, contract knowledge, and operating continuity in a government-services business. Continued involvement from the former CEO as an adviser and director may further reduce disruption during the transition.
Broad Federal Mission-support CapabilitiesDLH’s combination of healthcare, analytics, program management, and technical capabilities supports participation across multiple federal mission areas. This breadth can strengthen customer relevance and create opportunities to retain or expand work as agency priorities evolve.
Bears Say
Revenue Decline And Net LossesThe recent contraction in revenue and return to net losses indicate weaker demand, reduced operating leverage, and pressure on earnings quality. If this trajectory persists, DLH may have less capacity to reinvest, absorb contract setbacks, or improve returns for shareholders.
Elevated LeverageDebt exceeding equity leaves DLH with less financial flexibility as operating performance weakens. Elevated leverage can constrain capital allocation and increase sensitivity to earnings volatility, while negative returns suggest the balance sheet is not currently producing attractive shareholder profitability.
Declining Free Cash Flow CushionPositive free cash flow is supportive, but its sharp TTM decline reduces the cushion available for debt repayment, investment, and unexpected operating needs. Moderate coverage versus operating profit also suggests cash generation could become less protective if weak profitability continues.
DLH Holdings News
TS8A FAQ
What was DLH Holdings’s price range in the past 12 months?
DLH Holdings lowest stock price was €3.36 and its highest was €6.90 in the past 12 months.
What is DLH Holdings’s market cap?
DLH Holdings’s market cap is €49.18M.
When is DLH Holdings’s upcoming earnings report date?
DLH Holdings’s upcoming earnings report date is Dec 07, 2026 which is in 87 days.
How were DLH Holdings’s earnings last quarter?
DLH Holdings released its earnings results on Jul 29, 2026. The company reported -€1.008 earnings per share for the quarter, missing the consensus estimate of -€0.148 by -€0.86.
Is DLH Holdings overvalued?
According to Wall Street analysts DLH Holdings’s price is currently Undervalued.
Does DLH Holdings pay dividends?
DLH Holdings does not currently pay dividends.
What is DLH Holdings’s EPS estimate?
DLH Holdings’s EPS estimate is -0.24.
How many shares outstanding does DLH Holdings have?
DLH Holdings has 14,493,035 shares outstanding.
What happened to DLH Holdings’s price movement after its last earnings report?
DLH Holdings reported an EPS of -€1.008 in its last earnings report, missing expectations of -€0.148. Following the earnings report the stock price went up 1.333%.
Which hedge fund is a major shareholder of DLH Holdings?
Currently, no hedge funds are holding shares in DE:TS8A
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
DLH Holdings Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€6.01 (58.25% Upside)
€6.01 (58.25% Upside)
Blogger Sentiment
Bullish
DE:TS8A Sentiment 100%
Sector Average 58%
Sector Average 58%
Insider Transactions
Bought Shares
Worth €473.8K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
-32.38%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-14.88%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
DLH Holdings
DLH Holdings Corp., headquartered in Atlanta, Georgia, was established in 1969 and operated as TeamStaff, Inc. until its name change in June 2012. The company specializes in offering a range of technology-enabled business process outsourcing, comprehensive program management solutions, and public health research and analytics services throughout the United States, with a primary focus on the federal health services market. A significant portion of DLH's work involves defense and veterans' health, where it delivers integrated healthcare, technology, and logistical support. Key clients in this sector include the Department of Veterans Affairs (VA), the Defense Health Agency, the Tele-medicine and Advanced Technology Research Center, the Navy Bureau of Medicine and Surgery, and the Army Medical Research and Material Command. Additionally, the company provides diverse human services and solutions, covering areas such as rigorous monitoring and evaluation, efficient electronic medical records migration, robust data collection and management, and thorough nutritional and social health assessments. It also offers expert IT system architecture design, strategic migration planning, and continuous maintenance services. In the sphere of public health and life sciences, DLH undertakes crucial initiatives like clinical trials, epidemiological studies, and disease prevention. It actively promotes health among underserved and at-risk communities through the creation of impactful strategic communication campaigns, research into emerging health trends, in-depth health informatics analyses, and the application of proven best practices.
TS8A Company Deck
TS8A Earnings Call
Q3 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call communicated a mixed picture: material near-term financial headwinds with a steep year-over-year revenue decline (~33.5%) and a sharp drop in adjusted EBITDA (~43.6%), largely driven by program transitions to small business set-asides and contract completions. Offsetting these negatives, management reported margin resilience (9% adjusted EBITDA margin), positive free cash flow (~$3.8M), resumed deleveraging (debt reduced to $132.7M), a two-year NIH contract extension adding revenue visibility, recognition for technology capabilities, and an improving pipeline as delayed procurements return to market. Risks remain around federal health reprioritization and typical government procurement timing uncertainty, but the company appears to be stabilizing its cost structure and positioning for upcoming opportunities.View all DE:TS8A earnings summariesTS8A Stock 12 Month Forecast
Average Price Target
€6.01
▲(58.25% Upside)